Skip to main content

Table 6 Bleeding complications in patients with or without cancer (safety population)

From: Heparin based prophylaxis to prevent venous thromboembolic events and death in patients with cancer - a subgroup analysis of CERTIFY

All patients

Pts with cancer at admission

Pts without cancer at admission

OR (95%CI)

p-value*

 

n/avail.

%

n/avail.

%

  

Bleeding complications

      

   with major bleeding

2/274

0.73

15/2965

0.51

1.45 (0.33-6.36)

0.6254

   with minor bleeding

9/274

3.28

101/2965

3.41

0.96 (0.48-1.93)

0.9152

  1. Legend: Pts, patients; SD, UFH, unfractionated heparin; OR, odds ratio; CI, confidence interval, * two-sided p-value for null-hypothesis: difference = 0 or odds ratio = 1.
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us